Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $1.3
Cantor Fitzgerald analyst Gareth Gacetta maintains Upexi (NASDAQ: UPXI ) with a Overweight and lowers the price target from $2 to $1.3.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.